The spatial organization of metal nanoparticles has become an important tool for manipulating light in nanophotonic applications. Silver nanoparticles, particularly silver nanorods, have excellent plasmonic properties but are prone to oxidation and are therefore inherently unstable in aqueous solutions and salt-containing buffers. Consequently, gold nanoparticles have often been favored, despite their inferior optical performance. Bimetallic, i.e., gold-silver core-shell nanoparticles, can resolve this issue. We present a method for synthesizing highly stable gold-silver core-shell NRs that are instantaneously functionalized with DNA, enabling chiral self-assembly on DNA origami. The silver shell gives rise to an enhancement of plasmonic properties, reflected here in strongly increased circular dichroism, as compared to pristine gold nanorods.  https://www.selleckchem.com/products/epacadostat-incb024360.html  Gold-silver nanorods are ideal candidates for plasmonic sensing with increased sensitivity as needed in pathogen RNA or antibody testing for nonlinear optics and light-funneling applications in surface enhanced Raman spectroscopy. Furthermore, the control of interparticle orientation enables the study of plasmonic phenomena, in particular, synergistic effects arising from plasmonic coupling of such bimetallic systems.The effects of Zn-Pt interaction and Pt dispersion over a uniform compact cylindrical shape ZSM-5 (UZSM-5) on the catalytic octane aromatization performance are investigated. The comparison between different Pt- and Zn-modified ZSM-5 catalysts demonstrates the significance of ZSM-5 morphology and, more importantly, the metal distributions on it. For the UZSM-5 support, Pt atoms prefer to occupy the sites within its inner pores, resulting in high selectivity to xylenes during the octane aromatization. The Zn deposit in inner pores and higher dispersion of Pt lead to the spillover of Pt sites to the external surface, which is critical for the activation of octane to produce reaction intermediates that are further converted to aromatics over the inner pore catalytic sites. These effects are evidenced by a diffuse reflection infrared Fourier transform spectroscopy study of CO adsorbed on the catalyst surface. In situ X-ray absorption fine structure spectra are collected to probe the coordination number and the chemical environment of Pt and Zn atoms in the catalysts during the octane aromatization reaction. Pt and Zn are well dispersed and stable during the reaction, and a partial reduction of Pt during the reaction is observed. A theoretical study using the density functional theory method predicts that the reaction and transition-state intermediates upon octane activation are better stabilized by Pt(111) of Pt external surface sites with a smaller activation barrier, indicating their significance in C-H activation. This hypothesis is further evidenced by comparing the octane aromatization performance of various modified catalysts through varying Zn loading, blocking inner pores, and covering the external catalytic sites with SiO2.Förster resonant energy transfer (FRET)-mediated exciton diffusion through artificial nanoscale building block assemblies could be used as an optoelectronic design element to transport energy. However, so far, nanocrystal (NC) systems supported only diffusion lengths of 30 nm, which are too small to be useful in devices. Here, we demonstrate a FRET-mediated exciton diffusion length of 200 nm with 0.5 cm2/s diffusivity through an ordered, two-dimensional assembly of cesium lead bromide perovskite nanocrystals (CsPbBr3 PNCs). Exciton diffusion was directly measured via steady-state and time-resolved photoluminescence (PL) microscopy, with physical modeling providing deeper insight into the transport process. This exceptionally efficient exciton transport is facilitated by PNCs' high PL quantum yield, large absorption cross section, and high polarizability, together with minimal energetic and geometric disorder of the assembly. This FRET-mediated exciton diffusion length matches perovskites' optical absorption depth, thus enabling the design of device architectures with improved performances and providing insight into the high conversion efficiencies of PNC-based optoelectronic devices.An all-solid-state battery is a potentially superior alternative to a state-of-the-art lithium-ion battery owing to its merits in abuse tolerance, packaging, energy density, and operable temperature ranges. In this work, a 5 V-class spinel LiNi0.5Mn1.5O4 (LNMO) cathode is targeted to combine with a high-ionic-conductivity Li6PS5Cl (LPSCl) solid electrolyte for developing high-performance all-solid-state batteries. Aiming to passivate and stabilize the LNMO-LPSCl interface and suppress the unfavorable side reactions such as the continuous chemical/electrochemical decomposition of the solid electrolyte, oxide materials including LiNbO3, Li3PO4, and Li4Ti5O12 are rationally applied to decorate the surface of pristine LNMO particles with various amounts through a wet-chemistry approach. Electrochemical characterization demonstrates that the composite cathode consisting of 8 wt % LiNbO3-coated LNMO and LPSCl in a weight ratio of 7030 delivers the best electrochemical performance with an initial discharge capacity of 115 mA h g-1 and a reversible discharge capacity of 80 mA h g-1 at the 20th cycle, suggesting that interfacial passivation is an effective strategy to ensure the operation of 5 V-class all-solid-state batteries.Purpose Proteomic biomarkers have been emerging as alternative methods to the gold standard procedures of cystoscopy and urine cytology in the diagnosis and surveillance of bladder cancer (BC). This review aims to update the state of the art of proteomics research and diagnosis in BC. Materials and methods We reviewed the current literature related to BC research on urinary, tissue, blood and cell line proteomics, using the Pubmed database. Findings Two urinary protein biomarkers are FDA-approved (NMP22® and BTA® tests), only if performed along with cystoscopy for surveillance after initial diagnosis, but not in the primary diagnostic setting due to high false-positive rates in case of infections, stones and hematuria. There are a great number of non-FDA approved proteins being studied, with good preliminary results; panels of proteins seem valuable tools to be refined in ongoing trials. Blood proteins are a bigger challenge, because of the complexity of the serum protein profile and the scarcity of blood proteomic studies in BC.